Quantitative p21waf-1/p53 immunohistochemical analysis defines groups of primary invasive breast carcinomas with different prognostic indicators

International Journal of Cancer

Volumn 95, Issue 2, 2001, Pages 128-134

  Ceccarelli, C ^a   Santini, D ^a,b   Chieco, P ^a   Lanciotti, C ^a   Taffurelli, M ^a   Paladini, G ^a   Marrano, D ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Human breast cancer; Ki 67; p21waf 1 proteins; p53 protein; Prognostic molecular classification

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; HORMONE; HORMONE RECEPTOR; KI 67 ANTIGEN; PROGESTERONE; PROGESTERONE RECEPTOR; PROTEIN P21; PROTEIN P53; TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER HORMONE THERAPY; CANCER SURVIVAL; DNA DAMAGE; FEMALE; HUMAN; HUMAN TISSUE; IMAGE CYTOMETRY; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REGRESSION ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, MEDULLARY; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DISEASE-FREE SURVIVAL; DNA DAMAGE; FEMALE; HUMANS; IMAGE CYTOMETRY; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LYMPHATIC METASTASIS; MIDDLE AGED; MULTIVARIATE ANALYSIS; MUTATION; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TIME FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0035916982     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(20010320)95:2<128::AID-IJC1022>3.0.CO;2-D     Document Type: Article

References (35)

1. Participation of p53 protein in the cellular response to DNA damage
2. Wild-type p53 is a cell cycle checkpoint determinant following irradiation
3. Thymocyte apoptosis induced by p53-dependent and independent pathways
4. p53 in tumour pathology: Can we trust immunohistochemistry? Revised!
5. p53 expression in breast cancer
6. p53 allele losses, mutations and expression in breast cancer and their relationship to clinicopathological parameters
7. Association among p53 gene mutation, nuclear accumulation of the p53 protein and aggressive phenotype in breast cancer
8. The p53 tumor suppressor gene in breast cancer
9. P53 in breast carcinomas: Association between presence of mutation and immunohistochemical expression using a semiquantitative approach
10. P53 protein detected by immunohistochemical staining is not always mutant
11. Cip1/Waf-1/Sdi
12. Loss of function and p53 protein stabilization
13. Why is p53 protein stabilized in neoplasia? Some answers but many more question!
14. Overexpression of the oncoprotein p53 in primary hepatic tumors of childhood does not correlate with gene mutation
15. Topological control of p21 WAF-1 expression in normal and neoplastic tissue
16. p21/p53, cellular growth control and genomic integrity
17. Transforming growth factor B1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cells
18. p53-independent expression of the cyclin-dependent kinase inhibitor p21 in pancreatic carcinoma
19. p21 WAF1/CIP1 expression in normal mucosa and in adenomas and adenocarcinomas of the colon: Its relationship with differentiation
20. Regulation of p21 WAF1/CIP1 expression through mitogen-activated protein kinase signalling pathway
21. p21 RNA and protein expression in non-small cell lung carcinomas: Evidence of p53-independent expression and association with tumoral differentiation
22. WAF1/CIP1 in non-neoplastic mucosa and neoplasia of the stomach: Relationship with p53 status and proliferative activity
23. WAF1/Cip1 expression is associated with cell differentiation but not with p53 mutations in squamous cell carcinomas of the larynx
24. Mechanisms of regulation of waf1/cip1 gene expression in human breast carcinoma: Role of p53-dependent and independent signal transduction pathways
25. Functional analysis of a p21 WAF1/Cip1/SDI1 mutant (Arg94Trp) identified in a human breast carcinoma
26. Prognostic value of p21WAF1 and p53 expression in breast carcinoma: An immunohistochemical study of 261 patients with long-term follow-up
27. CCND1 expression and tubular differentiation but is independent of p53 overexpression in human breast carcinoma
28. p21(Waf1Cip1) and p53 protein expression in breast cancer
29. Pathological prognostic factors in breast cancer. 1. The value of histological grade in breast cancer: Experience from a large study with long-term follow-up
30. Cytometric measurement of cell proliferation in echo-guided biopsies from focal lesions of the liver
31. Quantitative study of Ki67 antibody staining in non-Hodgkin's lymphoma using image analysis
32. Principal component analysis and exploratory factor analysis
33. Review of survival analysis published in cancer journals
34. Regression models and life tables